First Mpox (monkeypox) test kit approved for Australia
Published
Related content
-
Company issued $12,600 infringement notice for alleged COVID-19 advertising breach
The TGA has issued a $12,600 infringement notice to Melbourne based company NutriPATH Pty Ltd for the alleged unlawful advertising of a COVID-19 Polymerase Chain Reaction (PCR) test collection kit. -
Warning about products claiming to treat or prevent the novel coronavirus
The TGA has identified certain therapeutic goods being inappropriately promoted for the prevention or treatment of novel coronavirus (2019-nCoV) infections in Australia -
Australia's first COVID treatment approved
The TGA has granted provisional approval to remdesivir ("Veklury", Gilead Sciences Pty Ltd) as the first treatment option for COVID-19.